Michael Secora
CFO & Chief Corp Dev Ofcr · 1 filing · Latest: Oct 14, 2026
Iambic Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
RXRX | Secora Michael | — | Jan 17, 2025 | Proposed Sale | $6.51 | 5,000 | $32.6K | — | |
RXRX | Secora Michael | — | Jan 15, 2025 | Proposed Sale | $6.57 | 15,000 | $98.5K | — | |
RXRX | Secora Michael | — | Jan 14, 2025 | Proposed Sale | $6.48 | 15,000 | $97.2K | — | |
RXRX | Secora Michael | — | Dec 11, 2024 | Proposed Sale | $7.48 | 15,000 | $112.2K | — | |
RXRX | Secora Michael | — | Dec 10, 2024 | Proposed Sale | $7.75 | 15,000 | $116.3K | — | |
RXRX | Secora Michael | — | Nov 13, 2024 | Proposed Sale | $7.66 | 15,000 | $114.9K | — | |
RXRX | Secora Michael | — | Oct 9, 2024 | Proposed Sale | $6.36 | 15,000 | $95.4K | — | |
RXRX | Secora Michael | — | Oct 8, 2024 | Proposed Sale | $6.32 | 15,000 | $94.8K | — | |
RXRX | Secora Michael | — | Sep 11, 2024 | Proposed Sale | $6.32 | 15,000 | $94.7K | — | |
RXRX | Secora Michael | — | Sep 10, 2024 | Proposed Sale | $6.17 | 15,000 | $92.5K | — | |
RXRX | Secora Michael | — | Nov 12, 2024 | Proposed Sale | $7.52 | 15,000 | $112.8K | — |